ABBV-744 IN COMBINATION WITH IMMUNOTHERAPY - AN OVERVIEW

More studies in progress suggest that ARV-825 may also be effective in boosting the response to estrogen deprivation (aromatase inhibition), another ingredient of ordinary of care in ER+ breast cancer.Overall, our latest work highlights the potential utilization of ARV-825 in combination with TAM. Even though ABBV-744 could also suppress proliferat